TVTX
Travere Therapeutics, Inc.
$51.56−0.48 (−0.92%)Close Nov 12, 2026
Nov 8, 2012 – Nov 12, 2026, Dividends reinvested
- Final balance
- $343,733
- CAGR
- +28.72%
- Max drawdown
- −85.43%
- Sharpe ratio
- 0.63
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
TVTX's average annual return was 9.31% over the last 10 years, through Nov 12, 2026. $10,000 in TVTX on Nov 11, 2016 grew to $24,367 by Nov 12, 2026, with dividends reinvested.
Total
- 1M
- −0.88%
- 3M
- −17.05%
- 6M
- +20.35%
- YTD
- +34.94%
- 1Y
- +41.38%
Per year
- 3Y
- +109.84%
- 5Y
- +11.58%
- 10Y
- +9.31%
- Since 2012
- +28.72%
Annual returns
2012 from Nov 8 · 2026 through Nov 12
TVTX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 12 | +34.94% |
| 2025 | +119.35% |
| 2024 | +93.77% |
| 2023 | −57.25% |
| 2022 | −32.25% |
| 2021 | +13.89% |
| 2020 | +91.94% |
| 2019 | −37.25% |
| 2018 | +7.40% |
| 2017 | +11.30% |
| 2016 | −1.87% |
| 2015 | +57.60% |
| 2014 | +74.86% |
| 2013 | +108.96% |
| 2012 from Nov 8 | +123.33% |
Metrics
Since 2012| Volatility | 96.45% |
|---|---|
| Sortino ratio | 1.30 |
| Calmar ratio | 0.34 |
| Best year, 2025 | +119.35% |
| Worst year, 2023 | −57.25% |
| Positive years | 9 of 13 |
| Longest drawdown | 10.3 years |
Worst drawdowns
Since 2012| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −85.4% | Aug 2015 | Apr 2024 | Nov 2025 | 10.3 years |
| −65.4% | Apr 2014 | Nov 2014 | Mar 2015 | 1 year |
| −62.3% | Dec 2012 | Dec 2012 | May 2013 | 5 months |
| −48.6% | May 2013 | Aug 2013 | Jan 2014 | 8 months |
| −46.8% | Dec 2012 | Dec 2012 | Dec 2012 | 6 days |